Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pharmaceuticals
Groups Back Vaccines For Malaria And Hiv
October 6, 2008
| A version of this story appeared in
Volume 86, Issue 40
The Bill & Melinda Gates Foundation will provide $168.7 million to the PATH Malaria Vaccine Initiative, which is working on a malaria vaccine with GlaxoSmithKline Biologicals. The funding was unveiled at the United Nations Millennium Development Goals Malaria Summit, where almost $3 billion in malaria-fighting grants were announced. Meanwhile, Scripps Research Institute and the International AIDS Vaccine Initiative are spending $30 million on a new research center at Scripps dedicated to vaccines that elicit broadly neutralizing antibodies against HIV.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter